Theraclion S.A.

ALTHE.PA · PAR
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Market Cap€15,257€17,744€26,566€29,828
- Cash€4,171€7,815€2,489€2,462
+ Debt€1,296€1,951€2,510€2,394
Enterprise Value€12,381€11,880€26,588€29,760
Revenue€830€1,822€1,235€1,481
% Growth-54.5%47.5%-16.6%
Gross Profit-€7,183-€1,080-€3,050-€4,540
% Margin-865.4%-59.3%-246.9%-306.5%
EBITDA-€6,960-€4,487-€5,740-€4,404
% Margin-838.6%-246.3%-464.6%-297.4%
Net Income-€5,757-€3,675-€4,964-€3,760
% Margin-693.6%-201.7%-401.8%-253.9%
EPS Diluted-0.12-0.076-0.17-0.16
% Growth-57.7%55.2%-6.3%
Operating Cash Flow-€2,911-€2,485-€5,266-€3,884
Capital Expenditures-€102-€112-€323-€148
Free Cash Flow-€3,013-€2,597-€5,589-€4,032
Theraclion S.A. (ALTHE.PA) Financial Statements & Key Stats | AlphaPilot